KLB Blocking Peptide (N-Term)
€363.00
In stock
SKU
AC-BP22050a
Background:
Contributes to the transcriptional repression of cholesterol 7-alpha-hydroxylase (CYP7A1), the rate-limiting enzyme in bile acid synthesis. Probably inactive as a glycosidase. Increases the ability of FGFR1 and FGFR4 to bind FGF21 (By similarity).
Other Names:
Beta-klotho, BKL, BetaKlotho, Klotho beta-like protein, KLB
Target/Specificity:
The synthetic peptide sequence is selected from aa 18-29 of HUMAN KLB
Gene Name: KLB
Gene ID: 152831
Primary Accession: Q86Z14
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Contributes to the transcriptional repression of cholesterol 7-alpha-hydroxylase (CYP7A1), the rate-limiting enzyme in bile acid synthesis. Probably inactive as a glycosidase. Increases the ability of FGFR1 and FGFR4 to bind FGF21 (By similarity).
Other Names:
Beta-klotho, BKL, BetaKlotho, Klotho beta-like protein, KLB
Target/Specificity:
The synthetic peptide sequence is selected from aa 18-29 of HUMAN KLB
Gene Name: KLB
Gene ID: 152831
Primary Accession: Q86Z14
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review